The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Engineer, Misha
    Director born in January 1983
    Individual (7 offsprings)
    Officer
    2012-10-22 ~ now
    OF - Director → CIF 0
    Ms Misha Engineer
    Born in January 1983
    Individual (7 offsprings)
    Person with significant control
    2017-11-28 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
Ceased 2
  • 1
    Mr Navinchandra Jamnadas Engineer
    Born in May 1951
    Individual (1 offspring)
    Person with significant control
    2016-04-06 ~ 2017-11-28
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 2
    Mrs Varsha Navinchandra Engineer
    Born in September 1954
    Individual (7 offsprings)
    Person with significant control
    2016-04-06 ~ 2017-11-28
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
parent relation
Company in focus

SURREY PHARMA LTD

Standard Industrial Classification
21200 - Manufacture Of Pharmaceutical Preparations
Brief company account
Total Inventories
1,685 GBP2023-10-31
3,472 GBP2022-10-31
Debtors
967 GBP2023-10-31
2,860 GBP2022-10-31
Cash at bank and in hand
12,975 GBP2023-10-31
24,536 GBP2022-10-31
Current Assets
15,627 GBP2023-10-31
30,868 GBP2022-10-31
Creditors
Current, Amounts falling due within one year
-269,585 GBP2023-10-31
-295,234 GBP2022-10-31
Net Current Assets/Liabilities
-253,958 GBP2023-10-31
-264,366 GBP2022-10-31
Equity
Called up share capital
2 GBP2023-10-31
2 GBP2022-10-31
Retained earnings (accumulated losses)
-253,960 GBP2023-10-31
-264,368 GBP2022-10-31
Equity
-253,958 GBP2023-10-31
-264,366 GBP2022-10-31
Average Number of Employees
12022-11-01 ~ 2023-10-31
12021-11-01 ~ 2022-10-31
Trade Debtors/Trade Receivables
Current
967 GBP2023-10-31
2,640 GBP2022-10-31
Other Debtors
Amounts falling due within one year
0 GBP2023-10-31
220 GBP2022-10-31
Debtors
Current, Amounts falling due within one year
967 GBP2023-10-31
2,860 GBP2022-10-31
Trade Creditors/Trade Payables
Current
0 GBP2023-10-31
41 GBP2022-10-31
Other Taxation & Social Security Payable
Current
2,520 GBP2023-10-31
2,328 GBP2022-10-31
Other Creditors
Current
267,065 GBP2023-10-31
292,865 GBP2022-10-31
Creditors
Current
269,585 GBP2023-10-31
295,234 GBP2022-10-31

  • SURREY PHARMA LTD
    Info
    Registered number 08263113
    Unit 7 Martinfield Business Centre, Welwyn Garden City AL7 1HG
    Private Limited Company incorporated on 2012-10-22 (12 years 8 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-22
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.